GLP-1/glucagon receptor (dual) drugs for MASH / NASH

5 tracked GLP-1/glucagon receptor (dual) drugs in the MASH / NASH race. The class explanation lives on the GLP-1/glucagon receptor (dual) page; the full indication pipeline across every mechanism is on the MASH / NASH page.

2 Phase 32 Phase 21 Phase 1/2

Head-to-head evidence: OPK-88006 vs Zabopegdutide · OPK-88006 vs pemvidutide · OPK-88006 vs survodutide · efinopegdutide vs Zabopegdutide · pemvidutide vs Zabopegdutide · survodutide vs Zabopegdutide

The roster

← all GLP-1/glucagon receptor (dual) drugs